Gene therapy with etranacogene dezaparvovec in haemophilia B: about the 1st patient infused in Spain
Revista Hemostasia y Trombosis · 30.10.2026 · 3 (2)
DOI: 10.24875/rht.m26000094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Hemostasia y Trombosis, online erschienen am 30.10.2026. Verfasst von Antia Amoedo-Bastos und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Amoedo-Bastos, A., Albo-López, C., Romero-Ventosa, E. Y., Rodríguez-López, M., López-Ansoar, M. E., Sar-Fuente, P., Iglesias-Varela, R., & Ocampo-Martínez, R. (2026). Gene therapy with etranacogene dezaparvovec in haemophilia B: about the 1st patient infused in Spain. Revista Hemostasia y Trombosis, 3(2). https://doi.org/10.24875/rht.m26000094
Vancouver
Amoedo-Bastos A, Albo-López C, Romero-Ventosa EY, Rodríguez-López M, López-Ansoar ME, Sar-Fuente P, et al. Gene therapy with etranacogene dezaparvovec in haemophilia B: about the 1st patient infused in Spain. Revista Hemostasia y Trombosis. 2026;3(2). doi:10.24875/rht.m26000094
BibTeX
@article{AmoedoBastos2026,
author = {Amoedo-Bastos, Antia and Albo-López, Carmen and Romero-Ventosa, Elena Y. and Rodríguez-López, Manuel and López-Ansoar, María E. and Sar-Fuente, Paula and Iglesias-Varela, Raquel and Ocampo-Martínez, Raquel},
title = {Gene therapy with etranacogene dezaparvovec in haemophilia B: about the 1st patient infused in Spain},
journal = {Revista Hemostasia y Trombosis},
year = {2026},
volume = {3},
number = {2},
doi = {10.24875/rht.m26000094}
}
EUVIMED